Earnings Per Share, Basic in USD/shares of Propanc Biopharma, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Propanc Biopharma, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q1 2021 to Q3 2025.
  • Propanc Biopharma, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.39 USD/shares, a 98.9% increase year-over-year.
  • Propanc Biopharma, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 20 USD/shares.
  • Propanc Biopharma, Inc. annual Earnings Per Share, Basic for 2025 was -14.9 USD/shares.
  • Propanc Biopharma, Inc. annual Earnings Per Share, Basic for 2024 was -1.42K USD/shares.
  • Propanc Biopharma, Inc. annual Earnings Per Share, Basic for 2023 was -1.8 USD/shares, a 96.3% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Propanc Biopharma, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $20.00 $0 +$35.60 +98.9% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 -$14 $65.90 Apr 1, 2025 Jun 30, 2025 10-K 2025-09-29
Q1 2025 -$13 +$533 +97.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 -$32 -$31 -1967% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-14
Q3 2024 -$36 -$36 -89825% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q1 2024 -$546 -$546 -$545 -129850% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 $0 -$2 -$1 -194% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-14
Q3 2023 $0 $0 +$2.09 +98.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$1 $1.28 +$50.50 Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 -$52 $0 $0 -4100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$51 -$1 -$1 -2550% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q3 2022 -$51 -$2 -$2 -10550% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$49 -$49 Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 $0 +$0.11 +91.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $0 Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16

Propanc Biopharma, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$15 +$1.41K Jul 1, 2024 Jun 30, 2025 10-K 2025-09-29
2024 -$1.42K* -$1.42K Jul 1, 2023 Jun 30, 2024 10-K 2025-09-29
2023 -$2 +$47.40 +96.3% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-30
2022 -$49 -$48 -6054% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-28
2021 -$1 Jul 1, 2020 Jun 30, 2021 10-K 2022-09-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.